Status:
COMPLETED
Effects of Low-intensity Shockwave Therapy Versus Kegel Exercises on Arteriogenic Erectile Dysfunction in DM Patients
Lead Sponsor:
Cairo University
Conditions:
Sexual Dysfunction
Shock Wave
Eligibility:
MALE
35-55 years
Phase:
NA
Brief Summary
* To assess the effectiveness of low-intensity shockwave therapy (Li-ESWT) in the management of Arteriogenic erectile dysfunction in diabetic patients. * To assess the effectiveness of Kegel Exercises...
Detailed Description
Erectile dysfunction is defined as the persistent inability to attain and maintain an erection enough to permit satisfactory sexual performance. Although ED is a benign disorder, it may affect physica...
Eligibility Criteria
Inclusion
- Ninety married men were diagnosed with T2DM participated in this study.
- The patients complained from arteriogenic ED \> 6 months (Reisman et al., 2015) before the participation in this study
- All patients aged between 35-55 years old.
- Glycated hemoglobin (HbA1c) less than 9%.
- Body mass index of the patients was \< 30 Kg/m2.
Exclusion
- Alcohol-abuse, illegal drug consumer patients.
- Patients with cardiac diseases that prevent or affect sexual activity (heart attack, stroke, heart failure, myocardial infarction life-threatening, arrhythmia, etc within the previous 6 months).
- Patients with any pulmonary, liver, or kidney diseases.
- Patients with neurological insults, spinal cord injuries, stroke, polyneuropathy, etc.
- Patients with diagnosed psychiatric/mental complaints.
- Patients with blood pressure of more than 140/90 mmHg.
- Patients with peripheral vascular disease.
- Patients with venogenic ED.
- Patients with past radical prostatectomy, extensive pelvic surgery, or previous pelvic trauma.
- Patients recovering from cancer in the past 5 years
- Penile anatomical abnormalities.
- Patients with clinically significant chronic hematological disease.
- Patients who received Anti-androgens or radiotherapy treatment of pelvic region.
- Patients with untreated hypogonadism.
- Patients with psychogenic ED (normal nocturnal penile tumescence parameters)
- Patient with penile prosthesis
Key Trial Info
Start Date :
January 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 6 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06058832
Start Date
January 5 2024
End Date
September 6 2024
Last Update
November 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alhussein Hospital
Cairo, Egypt, 3753450